F8J-33642-77384
3 vaccinations
1 coded response
7 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 554 / MN
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-09
Registered in v-safe
- 2021-04-09
- 2021-04-16
- 2021-06-04
- 2021-09-03
-
2021-11-11
Dose 2 — ModernaCo-administered: Flu
-
2022-03-07
Survey response — 12 months, dose 1MedDRA: COVID-19, Oropharyngeal pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid in December; sore throat for 6-8 weeks and moderate fever for 1 dayMedDRA releases: 2024-11 · check-in free text available
-
2022-09-17
Dose 3 — Pfizer-BioNTech
- 2022-10-16
- 2022-10-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-11 | Moderna | Flu |
| 3 | 2022-09-17 | Pfizer-BioNTech | No |
Free text
Release 11 — 12 months, dose 1
Symptoms: Covid in December; sore throat for 6-8 weeks and moderate fever for 1 day
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release